Search

New leads in the struggle against a formidable leukemia

December 04, 2015
A coordinated push to decrypt a complex form of leukemia is delivering a trove of new drug candidates and treatment ideas, a dozen of which will be presented at the American Society of Hematology Annual Meeting in Orlando, Florida (Dec. 5-8).
Leukemias with ALK mutations identified, may respond to ALK inhibitors

Leukemias with ALK mutations identified, may respond to ALK inhibitors

June 01, 2015
Mutations in the ALK gene were identified in the tumors of two leukemia patients, and laboratory studies indicated that leukemias harboring these mutations may respond to ALK inhibitors such as crizotinib and ceritinib, according to a study published in Cancer Research that was conducted by researchers with the Knight Cancer Institute at Oregon Health & Science University.
See More Stories